Lamda Laboratories

Lamda Laboratories is a Greece-based pharmaceutical contract development organization focused on research, development, regulatory affairs, and supply chain support for generic and specialty pharmaceutical products. The company has been particularly associated with generic, generic-plus, and value-added medicine development, with capabilities spanning formulation development, analytical services, scientific and clinical development, and dossier support. Its Athens/Koropi site has experience across more than 150 molecules and includes capabilities for HPAPI and controlled substances. Lamda Laboratories was acquired by Adragos Pharma in 2023 and now operates as Adragos' Athens development site while continuing to serve external pharmaceutical customers.